| 000 | 01288 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517075837.0 | ||
| 264 | 0 | _c20161213 | |
| 008 | 201612s 0 0 eng d | ||
| 022 | _a1744-8379 | ||
| 024 | 7 |
_a10.1586/14737167.2016.1148602 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoberts, M H | |
| 245 | 0 | 0 |
_aEconomic evaluations of fluticasone-propionate/salmeterol combination therapy for chronic obstructive pulmonary disease: a review of published studies. _h[electronic resource] |
| 260 |
_bExpert review of pharmacoeconomics & outcomes research _c2016 |
||
| 300 |
_a167-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBronchodilator Agents _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aFluticasone-Salmeterol Drug Combination _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBorrego, M E | |
| 700 | 1 | _aKharat, A A | |
| 700 | 1 | _aMarshik, P L | |
| 700 | 1 | _aMapel, D W | |
| 773 | 0 |
_tExpert review of pharmacoeconomics & outcomes research _gvol. 16 _gno. 2 _gp. 167-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737167.2016.1148602 _zAvailable from publisher's website |
| 999 |
_c25696645 _d25696645 |
||